Tag: SIR-Spheres Y-90 resin microspheres
DOORwaY90 clinical trial interim analysis demonstrates efficacy of Y-90 resin microspheres...
An interim analysis of the DOORwaY90 clinical trial has shown that yttrium-90 (Y-90) resin microspheres—SIR-Spheres (Sirtex)—using partition dosimetry, achieved high objective response rates and...
Sirtex receives expanded CE mark approval for SIR-Spheres Y90 resin microspheres
Sirtex Medical today announced that it has received an expanded CE mark approval for SIR-Spheres yttrium 90 (Y90) resin microspheres for the treatment of...
Sirtex Medical granted EU medical device regulation for Y90 resin micospheres
Sirtex Medical has today announced that it has received certification according to European medical device regulation (MDR) 2017/745 for SIR-Spheres Y90 resin microspheres and...
Multidisciplinary panel supports the positive role of SIRT at SUMM90YT conference
This advertorial is sponsored by Sirtex Medical, is only available in selected countries and geographies.
The SUMM90YT conference (23 February, Frankfurt, Germany)—hosted by Sirtex—gathered leading...
